Infectious disease
Ivermectin has become a contentious issue as to whether it effectively prevents and treats COVID-19. Several studies suggest it is effective, while others have indicated it is not.
The vaccine demonstrated efficacy in mild, moderate, and severe COVID-19 of 77.8% with efficacy against severe disease of 93.4%.
The WHO is calling for manufacturers to cut prices and increase the availability of supplies to low- and middle-income nations to parts of the world where COVID-19 continues to surge.
Continuing studies and news about COVID-19 around the world keeps coming in. Here’s a look.
Sheets of functionalized graphene quickly detected the SARS-CoV-2 virus in research conducted at the University of Illinois Chicago, paving the way for an alternative to PCR testing in the form of an accurate, real-time optical test for COVID-19.
The vaccine, dubbed ZyCoV-D, will be the first DNA vaccine available in the world if authorized by regulators.
It’s a busy news day for COVID-19-related stories. Read on for more.
The COVID-19 pandemic has led to faster R&D, faster approvals, faster science than ever before. It’s even leading to faster company development.
Here’s a look at some of the top COVID-19-related stories for today.
A new study published in Nature offers good news for those who recovered from COVID-19 and were then vaccinated with a mRNA vaccine – a booster may not be needed.
PRESS RELEASES